⌘K

Login Start Free

Home/Filings/4/0001127602-17-029530

4//SEC Filing

Molho Davide 4

Accession 0001127602-17-029530

CIK 0001100682other

View on SEC.gov Company Profile

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 12:17 PM ET

Size

8.6 KB

Accession

0001127602-17-029530

Insider Transaction Report

Form 4

Period: 2017-10-05

CHARLES RIVER LABORATORIES INTERNATIONAL INCCRL

Corporate Executive VP

Transactions

Exercise/Conversion
Common Stock
2017-10-05$76.67/sh+6,165$472,671→ 22,714 total
Sale
Common Stock
2017-10-05$110.00/sh−6,165$678,150→ 16,549 total
Exercise/Conversion
Stock Options (Right to Buy)
2017-10-05−6,165→ 12,330 total
Exercise: $76.67From: 2016-02-27Exp: 2020-02-27→ Common Stock (6,165 underlying)

Holdings

Common Stock
(indirect: By Trust)
47,017

Footnotes (1)

[F1]This sale occurred pursuant to a 10b5-1 Trading Plan.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL INC

CIK 0001100682

Entity typeother

Related Parties

1

filerCIK 0001507332

Filing Metadata

Form type: 4
Filed: Oct 5, 8:00 PM ET
Accepted: Oct 6, 12:17 PM ET
Size: 8.6 KB

View on SEC.gov